Issue

Vol. 64 No. 1: Issue 1

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Differentially expressed Secretoglobin 1C1 gene in nasal polyposis

https://doi.org/10.14715/cmb/2018.64.1.17
Sibel í–zdaş
Department of Bioengineering, Faculty of Engineering, Adana Science and Technology University, Adana, Turkey
Talih í–zdaş
Otolaryngology Clinic, Adana Education and Research Hospital, Adana, Turkey

Corresponding Author(s) : Sibel í–zdaş

sozdas@adanabtu.edu.tr

Cellular and Molecular Biology, Vol. 64 No. 1: Issue 1

Abstract

Nasal polyps (NP) are the most common pathological change that occurs in the nasal mucosa and is characterized by mucosal inflammation. Although its etiology and pathogenesis have not been clearly explained, its pathophysiology is arranged by the balance between pro-inflammatory and anti-inflammatory cytokines. The Secretoglobin 1C1 gene synthesizes odor molecule binding proteins (OBPs) in the nasal mucosa and regulates some cytokines. The Secretoglobin 1C1 gene expression could be disrupted by polymorphisms that may act as a possible cause of a disruption in the regulation of the promotor of the gene. Therefore, the main aim of this study was to determine the effects of Secretoglobin 1C1 gene promotor polymorphisms on the gene expression in NP.  In this study, to determine the relationship between the Secretoglobin 1C1 gene promotor polymorphisms and the gene expression, the levels of 48 subjects were sequenced (24 patients with NP and 22 controls without sinonasal disease). The levels' expression of Secretoglobin 1C1 in the subjects' nasal mucosa was also detected using RT-PCR.  In this study, the level of Secretoglobin 1C1's expression increased in NP (P= 0.003). Three polymorphisms were detected in the Secretoglobin 1C1 gene's promotor. The rs113795008 and rs2280540 variations were significantly high in NP (P= 0.005, P= 0.045). The the rs113795008 homozygous mutant type genotype (G/G) was associated with a high mRNA expression level of Secretoglobin 1C1 in NP (P= 0.009). A correlation was found between a high level of Secretoglobin 1C1 expression and its promotor polymorphism, which thus might increase and/or contribute to the susceptibility of developing NP in the Turkish population. These findings suggested that promotor variations in the function of the Secretoglobin 1C1 gene can alter the gene expression biology in NP.

Keywords

Nasal polyps (NP) Secretoglobin 1C1 gene Real-Time PCR Single nucleotide polymorphisms.
í–zdaş, S., & í–zdaş, T. (2018). Differentially expressed Secretoglobin 1C1 gene in nasal polyposis. Cellular and Molecular Biology, 64(1), 97–102. https://doi.org/10.14715/cmb/2018.64.1.17
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Larsen K, Tos M. The estimated incidence of symptomatie nasal polyps. Acta Otolaryngol 2002;122:179-82.
  2. Stankovic KM, Goldsztein H, Reh DD, Platt MP, Metson R. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope 2008;118:881-89.
  3. Bunnag C, Pacharee P, Vipulakom P. A study of allergic factor in nasal polyp patients. Ann Allergy 1983;50:126-36.
  4. Calenoff E, McMahan JT, Herzon GD, Kern RC, Ghadge GD, Hanson DG. Bacterial allergy in nasal polyposis. Arch Otolaryngol Head Neck Surg 1993;119:830-36.
  5. Cody D, Neel H, Ferreiro J, Roberts GD. Allergic fungal sinusitis: The Mayo Clinic Experience. Laryngoscope 1994;104:1076-79.
  6. Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory Cytokine Single Nucleotide Polymorphisms in Nasal Polyposis. Arch Otolaryngol Head Neck Surg 2007;133:705-09.
  8. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006;61:1280-89.
  9. Choi MS, Ray R, Zhang Z, Mukherjee AB. INF-gamma stimulates the expression of a novel secretoglobin that regulates chemotactic cell migration and invasion. J Immunol 2004;72:4245-52.
  10. Niimi T, Munakata M, Keck-Waggoner CL, Popescu NC, Levitt RC, Hisada M, Kimura S. A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk asthma. Am J Hum Genet 2002;70:718-25.
  11. Liu Z, Lu X, Zhang XH, Bochner BS, Long XB, Zhang F, et al. Clara cell 10-kDa protein expression in chronic rhino sinusitis and its cytokine-driven regulation in sinonasal mucosa. Allergy 2009;64:149-57.
  12. Cimmino M, Cavaliere M, Nardone M, Plantulli A, Orefice A, Esposito V, et al. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clin Otolaryngol Allied Sci 2003;28:125-32.
  13. Pinto JM, Hayes MG, Schneider D, Naclerio RM, Ober C. A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope 2008;118:2067-72.
  14. Mfuna-Endam L, Zhang Y, Desrosiers MY. Genetics of rhinosinusitis. Curr Allergy Asthma Rep 2011;11:236-46.
  15. Alexiou A, Sourtzi P, Dimakopoulou K, Manolis E, Velonakis E. Nasal polyps: heredity, allergies, and environmental and occupational exposure. J Otolaryngol Head Neck Surg 2011;40:58-63.
  16. Drake-Lee A. Nasal polyps in identical twins. J Laryngol Otol 1992;106:1084-95.
  17. Lockey RF, Rucknagel DL, Vanselow NA. Familial occurrence of asthma, nasal polyps and aspirin intolerance. Ann Intern Med 1973;8:57-63.
  18. Settipane G. Benefit/risk ratio of aspirin. NES Allergy Proceedings 1981;2:96-102.
  19. Haukim N, Bidwell JL, Smith AJP, Keen L, Gallagher G, Kimberly R, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun. 2002;3:313-30.
  20. Maloney J, Oliver R. HLA antigens, nasal polyps and asthma. Clin Otolaryngol 1980;5:183-89.
  21. Ramirez-Anguiano J, Yamamoto-Furusho JK, Barquera R, Beltran O, Granados J. Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. Otolaryngol Head Neck Surg 2006;135:90-93.
  22. Bernstein JM, Anon JB, Rontal M, Conroy J, Wang C, Sucheston L. Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis. Laryngoscope 2009;119:1258-64.
  23. Karjalainen J, Joki-Erkkila VP, Hulkkonen J, Pessi T, Nieminen MM, Aromaa A, et al. The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy 2003;58:393-96.
  24. Mfuna Endam L, Cormier C, Bosse Y, Filali-Mouhim A, Desrosiers M. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study. Arch Otolaryngol Head Neck Surg 2010;136:187-92.
  25. Wang X, Dong Z, Zhu DD, Guan B. Expression profile of immune-associated genes in nasalpolyps. Ann Otol Rhinol Laryngol 2006;115:450-56.
  26. Liu Z, Kim J, Sypek JP, Wang IM, Horton H, Oppenheim FG, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 2004;114:783-90.
  27. Fritz SB, Terrell JE, Conner ER, Kukowska-Latallo JF, Baker JR. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol 2003;112:1057-63.
  28. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN, et al. A synonymous SNP of the gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 2004;13:2361-68.
  29. Jarjanazi H, Savas S, Pabalan N, Dennis JW, Ozcelik H. Biological implications of SNPs in signal peptide domains of human proteins. Proteins 2008;1:394-03.
  30. Jackson BC, Thompson DC, Wright MW, McAndrews M, Bernard A, Nebert DW. Update of the human secretoglobin (SCGB) gene superfamily and an example of 'evolutionary bloom' of androgen-binding protein genes within the mouse Scgb gene superfamily. Hum Genomics 2011;5:691-02.
  31. Shijubo N, Itoh Y, Yamaguchi T, Imada A, Hirasawa M, Yamada T, et al. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am J Respir Crit Care Med 1999;1:930-33.
  32. Lu X, Wang N, Long XB, You XJ, Cui YH, Liu Z. The cytokine-driven regulation of secretoglobins in normal human upper airway and their expression, particularly that of uteroglobin-related protein 1, in chronic rhinosinusitis. Respir Res 2011;12:28-38.
  33. Reynolds SD, Reynolds PR, Pryhuber GS, Finder JD, Stripp BR. Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways. Am J Respir Crit Care Med 2002;166:1498-09.
  34. Pala M, í–zcan KM, í–zdaş S, Köseoğlu S, í–zdaş T, Erbek SS, et al. Investıgatıon of SCGB3A1 (UGRP2) gene arrays ın patıents wıth nasal polyposıs. EAORL-HNS 2014;271:3209-14.
  35. Dear TN, Boehm T, Keverne EB, Rabbitts TH. Novel genes for potential ligand-binding protein in subregions of the olfactory mucosa. EMBO J 1991;10:2813-19.
  36. Nordlund-Muller L, Andersson O, Ahlgren R, Schilling J, Gillner M, Gustafsson JA, et al. Cloning, structure, and expression of a rat binding protein for polychlorinated biphenyls. J Biol Chem 1990;265:12690-93.
  37. Lea OA, Petrusz P, French FS. Prostatein a major secretory protein of the rat ventral prostate. J Biol Chem 1979;254:6196-02.
  38. Orysiak J, Malczewska-Lenczowska J, Bik-Multanowski M. Expression of SCGB1C1 gene as a potential marker of susceptibility to upper respiratory tract infections in elite athletes – a pilot study. Biol Sport 2016;33:107-10
  39. í–zdaş S, ć°zbirak A, í–zdaş T, í–zcan KM, Erbek SS, Köseoğlu S, et al. Single-Nucleotide Polymorphisms on the RYD5 Gene in Nasal Polyposis. DNA Cell Biol 2015;34:633-42.
  40. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis Initiative: Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:155-212.
  41. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps Group: European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Supp 2007;l20:1-136.
  42. Mukherjee AB, Zhang Z, Chilton BS. Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily. Endocr Rev 2007;28:707-25.
  43. Inoue K, Wang X, Saito J, Tanino Y, Ishida T, Iwaki D, et al. Plasma UGRP1 levels associate with promoter G-112A polymorphism and the severity of asthma. Allergol Int 2008;57:57-64.
  44. Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998;8:1229-31.
  45. Drake-Lee AB. Nasal polyps. Em: Kerr AG, Groves J, editores. Scott-Brown's Otolaryngology. London: Butterworths 1987;147-53.
  46. B-Rao C. Sample size considerations in genetic polymorphism studies. Hum Hered 2001;52:191-10.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 862 Download : 329